ROBYN WILLIAMS: Open Payments
NPI 1740529155 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,190 in 74 payments from 12 companies in 2025. Trend: 2023 $522 · 2024 $213 · 2025 $1,190
Food & beverage: $1,190
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $369 |
| Ardelyx, Inc. | 9 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $159 |
| Phathom Pharmaceuticals, Inc. | 7 | $118 |
| Madrigal Pharmaceuticals | 5 | $105 |
| Lilly USA, LLC | 4 | $79 |
| GENZYME CORPORATION | 3 | $62 |
| Janssen Biotech, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $29 |
Products named: RINVOQ, IBSRELA, ENTYVIO, VOQUEZNA, REZDIFFRA, SKYRIZI, LINZESS, OMVOH.
Industry payments across TX — which companies pay providers there.
